Detection of mutations in plasma cell-free DNA of colorectal cancer patients and comparison with cancer panel data for tissue samples of the same cancers
Robust identification of genetic alterations is important for the diagnosis and subsequent treatment of tumors. Screening for genetic alterations using tumor tissue samples may lead to biased interpretations because of the heterogeneous nature of the tumor mass. Liquid biopsy has been suggested as a...
Saved in:
Main Authors: | Suji Min, Sun Shin, Yeun-Jun Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2019-11-01
|
Series: | Genomics & Informatics |
Subjects: | |
Online Access: | http://genominfo.org/upload/pdf/gi-2019-17-4-e42.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
by: Jieun Lee, et al.
Published: (2017-03-01) -
Comparison of tissue-based and plasma-based testing for mutation in non–small cell lung cancer patients
by: Yoon Kyung Kang, et al.
Published: (2025-01-01) -
Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC
by: Zhen Wu, et al.
Published: (2019-03-01) -
Validation of Customized Cancer Panel for Detecting Somatic Mutations and Copy Number Alterations
by: Su-Hye Choi, et al.
Published: (2017-12-01) -
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
by: Helena Bote-de Cabo, MD, et al.
Published: (2025-03-01)